Gene · 8650
Papers2,413
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 2,413
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| RNA splicing dysregulation and the hallmarks of cancer. | Nat Rev Cancer | 2023 | 36627445 | PubTator, text mining | PubMed |
| Notch1 signaling impairs regulatory T cells during multisystem inflammatory syndrome in children. | J Clin Invest | 2023 | 36594470 | PubTator, text mining | PubMed |
| Qing Fei Hua Xian Decoction ameliorates bleomycin-induced pulmonary fibrosis by suppressing oxidative stress through balancing ACE-AngII-AT1R/ACE2-Ang-(1-7)-Mas axis. | Iran J Basic Med Sci | 2023 | 36594067 | PubTator, text mining | PubMed |
| Blocking the Wnt/β‑catenin signaling pathway to treat colorectal cancer: Strategies to improve current therapies (Review). | Int J Oncol | 2023 | 36579676 | PubTator, text mining | PubMed |
| The US9-Derived Protein gPTB9TM Modulates APP Processing Without Targeting Secretase Activities. | Mol Neurobiol | 2023 | 36576708 | PubTator, text mining | PubMed |
| Differences in virtual and physical head orientation predict sickness during active head-mounted display-based virtual reality. | Virtual Real | 2023 | 36567954 | PubTator, text mining | PubMed |
| The Notch1/CD22 signaling axis disrupts Treg function in SARS-CoV-2-associated multisystem inflammatory syndrome in children. | J Clin Invest | 2023 | 36282598 | PubTator, text mining | PubMed |
| RUFY1 binds Arl8b and mediates endosome-to-TGN CI-M6PR retrieval for cargo sorting to lysosomes. | J Cell Biol | 2023 | 36282215 | PubTator, text mining | PubMed |
| Force tuning through regulation of clathrin-dependent integrin endocytosis. | J Cell Biol | 2023 | 36250940 | PubTator, text mining | PubMed |
| HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation. | Cell Mol Gastroenterol Hepatol | 2023 | 36244648 | PubTator, text mining | PubMed |
| TRIM67 drives tumorigenesis in oligodendrogliomas through Rho GTPase-dependent membrane blebbing. | Neuro Oncol | 2023 | 36215168 | PubTator, text mining | PubMed |
| Organization, dynamics and mechanoregulation of integrin-mediated cell-ECM adhesions. | Nat Rev Mol Cell Biol | 2023 | 36168065 | PubTator, text mining | PubMed |
| Numb chin syndrome: What all oral health care professionals should know. | J Am Dent Assoc | 2023 | 35644699 | PubTator, text mining | PubMed |
| Electrical charge on ferroelectric nanocomposite membranes enhances SHED neural differentiation. | Bioact Mater | 2023 | 35633875 | PubTator, text mining | PubMed |
| Gene Screening in High-Throughput Right-Censored Lung Cancer Data. | Onco (Basel) | 2022 | 37066112 | PubTator, text mining | PubMed |
| The role of histone methylase and demethylase in antitumor immunity: A new direction for immunotherapy. | Front Immunol | 2022 | 36713412 | PubTator, text mining | PubMed |
| Transcriptome and pan-cancer system analysis identify PM2.5-induced stanniocalcin 2 as a potential prognostic and immunological biomarker for cancers. | Front Genet | 2022 | 36685853 | PubTator, text mining | PubMed |
| A Landscape of CRISPR/Cas Technique for Emerging Viral Disease Diagnostics and Therapeutics: Progress and Prospects. | Pathogens | 2022 | 36678404 | PubTator, text mining | PubMed |
| Coping with Oxidative Stress in Reproductive Pathophysiology and Assisted Reproduction: Melatonin as an Emerging Therapeutical Tool. | Antioxidants (Basel) | 2022 | 36670948 | PubTator, text mining | PubMed |
| Aberrant Notch signaling in gliomas: a potential landscape of actionable converging targets for combination approach in therapies resistance. | Cancer Drug Resist | 2022 | 36627893 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8650/papers?page=15